Novavax delays timelines for COVID-19 vaccine regulatory filings, production
(Reuters) -Novavax Inc on Monday again delayed its timeline for ramping up COVID-19 vaccine production and said it does not expect to seek regulatory authorization for the shot in the United States, Britain and Europe until the third quarter of 2021, sending its shares tumbling.FILE PHOTO: A Novavax logo is reflected in a drop on a syringe needle in this […]
Read more